🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emily Hsu

University of Southern California

ORCID: 0000-0001-5096-0745

Also affiliated with University of California San Diego, USC Norris Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer”.

A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0285

N/A

0.614DataRank · unranked

59 citations

Jarwei Fang, Martha Salas, Catherine Do, Emily Hsu, Anna Zhukovskaya +9 more

Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters

Nucleic Acids Research(2024)10.1093/nar/gkae372

N/A

0.228DataRank · unranked

3 citations

Katherine Hutchison, Yao Liu, Charles M. Nicolet, Shannon Schreiner, Nathan R. Zemke +2 more

Persistent Activation of Endothelial Cells is Linked to Thrombosis and Inflammation in Cerebral Cavernous Malformation Disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.29.662238

N/A

0DataRank · unranked

2 citations

Eduardo Frías-Anaya, Cassandra Bui, Louie Zhao, Emily Hsu, Hannah S. Indralingam +6 more